Skip to main content

Suliman Shehnaaz

In the past year, 4 open-market sale filings worth $936.1K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$936.1K
4 filings
Net
−$936.1K
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Suliman Shehnaaz as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TXG 10x Genomics, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 18, 2026 (view filing)Jun 162 daysSuliman ShehnaazDirectorSSaleClass A Common Stock−5.72K$32.63−$186.8K−15.3%31.7K after2 lots10b5-1
Aug 26, 2026 (view filing)4:42 PM ETAug 242 daysSuliman ShehnaazDirectorSSaleClass A Common Stock−2.21K$63.65−$140.5K−7.0%29.5K after2 lots10b5-1
Sep 24, 2026 (view filing)4:30 PM ETSep 222 daysSuliman ShehnaazDirectorSSaleClass A Common Stock−5.72K$81.19−$464.7K−19.4%23.8K after5 lots10b5-1

RARE Ultragenyx Pharmaceutical Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 18, 2026 (view filing)May 18Same daySuliman ShehnaazDirectorSSale−5.74K$25.12−$144.2K−17.0%28.0K after10b5-1

ALEC Alector, Inc.

President and COO2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 10, 2021 (view filing)Dec 8-92 daysSuliman ShehnaazPresident and COOSSale−150.0K$22.81−$3.42M−59.4%102.6K after4 lots
Dec 14, 2021 (view filing)Dec 10-134 daysSuliman ShehnaazPresident and COOSSale−150.0K$21.50−$3.23M−59.4%102.6K after4 lots